Bundamedik Tbk PT (BMHS) - Total Liabilities

Latest as of December 2025: Rp1.62 Trillion IDR ≈ $95.04 Million USD

Based on the latest financial reports, Bundamedik Tbk PT (BMHS) has total liabilities worth Rp1.62 Trillion IDR (≈ $95.04 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Bundamedik Tbk PT - Total Liabilities Trend (2018–2025)

This chart illustrates how Bundamedik Tbk PT's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Bundamedik Tbk PT's working capital to evaluate short-term liquidity relative to the company's equity base.

Bundamedik Tbk PT Competitors by Total Liabilities

The table below lists competitors of Bundamedik Tbk PT ranked by their total liabilities.

Company Country Total Liabilities
Ryvu Therapeutics SA
WAR:RVU
Poland zł159.63 Million
Finder Energy Holdings Ltd
AU:FDR
Australia AU$891.40K
q.beyond AG
F:QBY
Germany €37.75 Million
Sao Mai Group Corp
VN:ASM
Vietnam ₫15.29 Trillion
RF Acquisition Corp II Ordinary Shares
NASDAQ:RFAI
USA $5.19 Million
TMT Steel Public Company Limited
BK:TMT
Thailand ฿5.04 Billion
Vaziva Sa
PA:ALVAZ
France €10.65 Million
Max India Limited
NSE:MAXIND
India Rs3.71 Billion

Liability Composition Analysis (2018–2025)

This chart breaks down Bundamedik Tbk PT's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Bundamedik Tbk PT.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.62 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.83 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.40 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bundamedik Tbk PT's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bundamedik Tbk PT (2018–2025)

The table below shows the annual total liabilities of Bundamedik Tbk PT from 2018 to 2025.

Year Total Liabilities Change
2025-12-31 Rp1.62 Trillion
≈ $95.04 Million
+24.90%
2024-12-31 Rp1.30 Trillion
≈ $76.09 Million
+1.21%
2023-12-31 Rp1.28 Trillion
≈ $75.19 Million
+13.51%
2022-12-31 Rp1.13 Trillion
≈ $66.24 Million
+12.94%
2021-12-31 Rp1.00 Trillion
≈ $58.65 Million
-10.06%
2020-12-31 Rp1.11 Trillion
≈ $65.21 Million
+51.37%
2019-12-31 Rp735.16 Billion
≈ $43.08 Million
+3.70%
2018-12-31 Rp708.92 Billion
≈ $41.54 Million
--

About Bundamedik Tbk PT

JK:BMHS Indonesia Medical Care Facilities
Market Cap
$91.25 Million
Rp1.56 Trillion IDR
Market Cap Rank
#19644 Global
#336 in Indonesia
Share Price
Rp181.00
Change (1 day)
+0.56%
52-Week Range
Rp147.00 - Rp226.00
All Time High
Rp1133.21
About

PT Bundamedik Tbk provides health care services in Indonesia. It also engages private hospital and healthcare support service activities; provision of ambulance services; private health education; consultant for reproductive technology services management; management consultant of physiotherapy service; and hotel, and dental clinic services management consulting businesses. It also provides ferti… Read more